Last deal

$5.3M

Amount

Series C

Stage

06.06.2011

Date

4

all rounds

$11.7M

Total amount

General

About Company
Regenesis Biomedical is a medical technology company that develops non-invasive regenerative medicine products.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1997

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

Their flagship product is the Provant Therapy System, which helps reduce pain and swelling of skin and soft tissues following surgery. Their customers include healthcare facilities and providers that serve patients being treated by acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home healthcare agencies, and wound care clinics. Regenesis Biomedical was founded in 1996 and is headquartered in Scottsdale, Arizona.
Contacts

Phone number

Social url